Allergy and Immunology · Northampton, MA
NPI
1588637102
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
269 Locust St, Suite 201
Northampton, MA, 01062
Phone (413) 586-0769
Groups this clinician bills Medicare through
Medicare paid, 2024
$261K
20,554 services
Medicare patients, 2024
929
Average age 70
Drug cost, 2024
$3.0M
2,172 prescriptions
Company payments, 2025
$66K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan L Bayuk was code 95165 (treatment - miscellaneous), 9,666 times for 557 patients. In total Jonathan L Bayuk billed 20,554 services in 33 codes, and Medicare paid $261K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-02-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 9,666 | 557 | $9.92 | $96K |
| 95004 Test - Miscellaneous | Office | 3,739 | 81 | $2.38 | $8,882 |
| 95117 Treatment - Miscellaneous | Office | 2,580 | 297 | $8.11 | $21K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 990 | 17 | $0.10 | $102 |
| 99214 Office E&M - Established | Office | 547 | 331 | $86.56 | $47K |
| 95024 Test - Miscellaneous | Office | 508 | 55 | $5.62 | $2,857 |
| 95115 Treatment - Miscellaneous | Office | 482 | 101 | $6.54 | $3,154 |
| 95149 Treatment - Miscellaneous | Office | 330 | 32 | $96.01 | $32K |
| 96372 Injection Administration | Office | 251 | 59 | $9.59 | $2,407 |
| 95017 Test - Miscellaneous | Office | 226 | 11 | $5.89 | $1,332 |
| 95148 Treatment - Miscellaneous | Office | 225 | 22 | $70.47 | $16K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 212 | 18 | $0.75 | $159 |
| 95018 Test - Miscellaneous | Office | 98 | 16 | $14.40 | $1,411 |
| 99204 Office E&M - New | Office | 92 | 92 | $108.06 | $9,941 |
| 99443 Telephone Services | Office | 66 | 61 | $84.21 | $5,558 |
By year: 2022 $265K for 17,432 services; 2023 $264K for 17,616 services; 2024 $261K for 20,554 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan L Bayuk prescribed most often to Medicare patients was Montelukast Sodium, with 144 prescriptions and refills. In total Jonathan L Bayuk wrote 2,172 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 144 | 335 | 44 | $2,133 |
| Xolair Omalizumab | 123 | 123 | 19 | $493K |
| Ipratropium Bromide Generic | 111 | 176 | 44 | $3,412 |
| Cromolyn Sodium Generic | 98 | 131 | 36 | $23K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 90 | 100 | 48 | $2,384 |
| Epinephrine Generic | 88 | 88 | 64 | $16K |
| Dupixent Pen Dupilumab | 80 | 80 | 11 | $303K |
| Dupixent Syringe Dupilumab | 79 | 80 | 11 | $307K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 75 | 103 | 18 | $64K |
| Levocetirizine Dihydrochloride Generic | 75 | 152 | 24 | $1,779 |
| Fluticasone Propionate Generic | 67 | 124 | 23 | $933 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 65 | 78 | 14 | $5,777 |
| Fluticasone Propionate Hfa Fluticasone Propionate | 54 | 70 | Under 11 | $15K |
| Azelastine Hcl Generic | 42 | 81 | 19 | $1,289 |
| Symbicort Budesonide/Formoterol Fumarate | 42 | 54 | Under 11 | $11K |
Brand drugs: 1,148 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jonathan L Bayuk $66K ($66K in general payments such as food, travel and fees) from 28 companies. The largest payer was Galderma Laboratories, L.P. with $34K.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 24 | $34K |
| AstraZeneca Pharmaceuticals LP AZN | 27 | $9,106 |
| Pfizer Inc. PFE | 26 | $7,802 |
| Pharming Healthcare, Inc. | 10 | $5,131 |
| Grifols Shared Services North America, Inc. | 1 | $2,138 |
| BioCryst Pharmaceuticals, Inc. BCRX | 1 | $1,850 |
| Grifols USA, LLC | 8 | $1,569 |
| Cycle Pharmaceuticals Inc | 4 | $1,452 |
| BioCryst US Sales Co., LLC | 18 | $322 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $308 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.